Mark J. Buchfuhrer

Internal Medicine

11480 Brookshire Ave
Downey, CA 90241

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Real-world effectiveness and safety of tonic motor activation therapy for refractory restless legs syndrome: 90-day outcomes from the THRIVE prospective observational study.

Real-world effectiveness and safety of tonic motor activation therapy for refractory restless legs syndrome: 90-day outcomes from the THRIVE prospective observational study.

Journal: Sleep

Published: January 30, 2026

An Updated Algorithm for the Management of Restless Legs Syndrome.

An Updated Algorithm for the Management of Restless Legs Syndrome.

Journal: Mayo Clinic proceedings

Published: January 08, 2026

The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines.

The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines.

Journal: Expert review of neurotherapeutics

Published: August 24, 2025

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial.

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial.

Journal: BMC neurology

Published: August 02, 2023

Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptoms.

Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptoms.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Published: March 01, 2023

Noninvasive neuromodulation reduces symptoms of restless legs syndrome.

Noninvasive neuromodulation reduces symptoms of restless legs syndrome.

Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Published: May 05, 2021

The Management of Restless Legs Syndrome: An Updated Algorithm.

The Management of Restless Legs Syndrome: An Updated Algorithm.

Journal: Mayo Clinic proceedings

Published: August 27, 2020

Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.

Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.

Journal: Sleep medicine

Published: July 09, 2018

In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome.

In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome.

Journal: Mayo Clinic proceedings

Published: February 28, 2018

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.

Journal: Mayo Clinic proceedings

Published: September 15, 2017

The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.

The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.

Journal: CNS drugs

Published: April 21, 2016

Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.

Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.

Journal: Sleep medicine

Published: November 28, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026